当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析 - 现金流量表

恒瑞医药

(600276)

  

流通市值:4145.08亿  总市值:4312.85亿
流通股本:63.79亿   总股本:66.37亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金15,666,363,464.516,090,507,617.7627,146,811,001.2520,000,144,131.46
  收到其他与经营活动有关的现金457,430,575.96211,428,920.531,322,070,742.88546,652,931.24
  经营活动现金流入小计16,123,794,040.476,301,936,538.2928,468,881,744.1320,546,797,062.7
  购买商品、接受劳务支付的现金910,938,758.61347,352,720.651,402,150,450.751,130,472,262.16
  支付给职工以及为职工支付的现金3,558,646,926.641,905,586,260.316,163,445,682.384,610,758,220.71
  支付的各项税费1,367,794,099.13652,139,252.42,290,150,446.161,652,291,637.65
  支付其他与经营活动有关的现金5,985,961,004.692,841,684,216.4211,190,382,126.138,567,828,933.06
  经营活动现金流出小计11,823,340,789.075,746,762,449.7821,046,128,705.4215,961,351,053.58
  经营活动产生的现金流量净额4,300,453,251.4555,174,088.517,422,753,038.714,585,446,009.12
二、投资活动产生的现金流量:
  收回投资收到的现金150,000,000150,000,000605,485,304.68200,000,000
  取得投资收益收到的现金29,112,592.2218,785,809.652,505,139.4543,037,372.95
  处置固定资产、无形资产和其他长期资产收回的现金净额3,719,423.421,568,511.6121,901,7398,183,649.5
  投资活动现金流入小计182,832,015.64170,354,321.21679,892,183.13251,221,022.45
  购建固定资产、无形资产和其他长期资产支付的现金1,267,564,947.42702,031,901.521,969,197,487.861,524,667,512.24
  投资支付的现金--622,680,411.5600,000,000
  投资活动现金流出小计1,267,564,947.42702,031,901.522,591,877,899.362,124,667,512.24
  投资活动产生的现金流量净额-1,084,732,931.78-531,677,580.31-1,911,985,716.23-1,873,446,489.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,351,937,892.28---
  取得借款收到的现金--799,909,380.08799,909,380.08
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计10,351,937,892.28-799,909,380.08799,909,380.08
  偿还债务支付的现金--799,909,380.08799,909,380.08
  分配股利、利润或偿付利息支付的现金1,274,130,192.8-1,274,788,274.051,274,788,274.05
  支付其他与筹资活动有关的现金1,038,312,699.07661,059,213.92275,801,751.83231,735,776.01
  筹资活动现金流出小计2,312,442,891.87661,059,213.922,350,499,405.962,306,433,430.14
  筹资活动产生的现金流量净额8,039,495,000.41-661,059,213.92-1,550,590,025.88-1,506,524,050.06
四、汇率变动对现金及现金等价物的影响48,287,663.4729,624,153.667,400,551.34-21,219,513.59
五、现金及现金等价物净增加额11,303,502,983.5-607,938,552.063,967,577,847.941,184,255,955.68
  加:期初现金及现金等价物余额24,239,102,117.6624,239,102,117.6620,271,524,269.7220,271,524,269.72
  期末现金及现金等价物余额35,542,605,101.1623,631,163,565.624,239,102,117.6621,455,780,225.4
补充资料:
  净利润4,454,670,657.21-6,336,994,647.53-
  资产减值准备9,443,508.19-32,538,341.38-
  固定资产和投资性房地产折旧347,244,043.34-655,021,624.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧347,244,043.34-655,021,624.88-
  无形资产摊销52,108,856.42-67,263,980.25-
  长期待摊费用摊销43,231,966.88-94,789,854.75-
  处置固定资产、无形资产和其他长期资产的损失-2,311,106.15--5,397,912.01-
  固定资产报废损失1,875,878.05-4,944,029.96-
  公允价值变动损失-111,263,854.42--108,630,771.57-
  财务费用-36,624,580.62--1,841,800.26-
  投资损失12,354,120.47--23,868,290.32-
  递延所得税-21,405,272.89--23,141,400.15-
  其中:递延所得税资产减少-32,699,770.72--56,618,467.73-
    递延所得税负债增加11,294,497.83-33,477,067.58-
  存货的减少-173,390,260.24--135,630,816.98-
  经营性应收项目的减少-691,831,578.87--375,699,363.85-
  经营性应付项目的增加280,027,724.23-671,408,644.5-
  其他126,931,999.62-209,255,274.64-
  现金的期末余额35,542,605,101.16-24,239,102,117.66-
  减:现金的期初余额24,239,102,117.66-20,271,524,269.72-
  现金及现金等价物的净增加额11,303,502,983.5-3,967,577,847.94-
公告日期2025-08-212025-04-252025-03-312024-10-25
审计意见(境内)标准无保留意见
TOP↑